Malinda Hurst is an experienced professional in quality management within the biotechnology and pharmaceutical sectors, currently serving as the Sr. Director of Quality Management at Prothena Corporation since November 2020. Prior roles include Director of Quality Management at the same company, as well as various positions focused on GXP and GMP quality assurance at Protagonist Therapeutics, ChemoCentryx, Gilead Sciences, XenoPort, Incline Therapeutics, Genentech, Depomed, Inc., Guidant, and Cor Therapeutics. Malinda Hurst holds a Bachelor of Science degree in Microbiology from San José State University, completed in 1991.
This person is not in any teams
This person is not in any offices